by Admin1-bct | Jan 23, 2023 | Life Sciences
A Utah-based nonprofit pharmaceutical manufacturer, Civica Rx, is on the verge of commencing production at its newly constructed Petersburg plant, following two years of construction and a $140 million investment. With production set to begin this year, the insulin...
by Admin1-bct | Jan 17, 2023 | Life Sciences
Entrepreneurs in Petersburg, Virginia, are establishing businesses to manufacture essential pharmaceuticals and address the shortage of generic drugs, which make up 90% of the medications taken, with the majority produced overseas. This initiative, as reported by...
by Admin1-bct | Jan 4, 2023 | Life Sciences
Starting this year, Medicare beneficiaries will have their out-of-pocket insulin costs capped at $35 per month as part of the 2022 Inflation Reduction Act. However, Civica Rx, a pharmaceutical company expanding in Petersburg, plans to produce insulin for everyone,...
by Admin1-bct | Dec 29, 2022 | Life Sciences
A nonprofit pharmaceutical company, Civica Inc., is set to offer insulin at a cost of no more than $30 per vial, making it much more affordable for the approximately 8 million Americans who rely on this life-saving medication. Civica, nearing the completion of a...
